Pricing
  1. US-listed companies
  2. Ascendis Pharma A
  3. Financials
  4. Pretax margin (%)

Ascendis Pharma A (ASND)

Market cap
P/E ratio
SummaryFinancials
Period EndPretax margin (%) YoY (%)
Dec 31, 2024-102.6-42.26%
Dec 31, 2023-177.8-84.26%
Dec 31, 2022-1,129.1-77.13%
Dec 31, 2021-4,936.3-18.12%
Dec 31, 2020-6,028.7+269.46%
Dec 31, 2019-1,631.8+32.31%
Dec 31, 2018-1,233.3-84.83%
Dec 31, 2017-8,129

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat